Short-Course versus Long-Course Preoperative Radiotherapy in Rectal Cancer: an Evidence Based Case report

Ayu Santika Santaningrum; Fenny Tjuatja; Giovano Andika Pradana; Hari Murti Wijaya; Jellyca Anton; Regina Wulandari; Sinta Prastiana Dewi; - Sudibio; Wahyu Diyana

doi:10.32532/jori.v8i2.70

Short-Course versus Long-Course Preoperative Radiotherapy in Rectal Cancer: an Evidence Based Case report

Ayu Santika Santaningrum, Fenny Tjuatja, Giovano Andika Pradana, Hari Murti Wijaya, Jellyca Anton, Regina Wulandari, Sinta Prastiana Dewi, - Sudibio, Wahyu Diyana

Sari

Background Surgery is the mainstay therapy for colorectal carcinoma with curative intent, while radiotherapy and chemotherapy act as adjuvant or neoadjuvant therapy. The desicion for surgery depends on tumor resectability. Neoadjuvant radiotherapy, both short-course radiotherapy (SRT) or long-course radiotherapy (LRT) with or without concurent chemtherapy, is aimed to increase tumor resectability. This article compares advantages of SRT and LRT.

Method We designed a search filter using relevant synonyms for the domain: “rectal carcinoma”, “resectable”, “preoperative radiotherapy”, and “short-course”. Publications are retrieved from PubMed, Cochrane Library, and EBSCO using MESH terms and search terms in title and abstract fields. Articles’ titles and abstracts from search result are screened for relevance. Eligible articles are selected based on inclusion and exclusion criterias. Selected articles are critically appraised for methods validity.

Result Six articles are included in our study, consists of four randomized clinical trials and four metaanalyses.

Conclusion SRT is as effective as LRT with or without chemotherapy in terms of overall survival, disease free survival, local recurrence rate, disease metastasis rate, free resection rate, and grade 3-4 toxicity. LRT with or without chemotherapy showed superiority in increasing pathological complete response rate and sphincter preservation rate. SRT is a better choice in centers with a long waiting list.

Kata Kunci

colorectal carcinoma, preoperative radiotherapy, preoperative, radiotherapy

Teks Lengkap:

PDF (English)

Referensi

International Agency for Research on Cancer. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012 [Internet]. 2012. Available from: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx

International Agency for Research on Cancer. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012 [INDONESIA]. 2012; Available from: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx

Komite Penanggulangan Kanker Nasional. Kanker kolorektal. Kementrian Kesehatan Republik Indonesia; 2017.

BD M. Cancer of the Rectum. In: R H, TL P, MIII R,

editors. Leibel and Phillips Textbook of Radiation Oncology. 3rd ed. Philadelphia: Saunders; 2010.

Manisha P, CG W. Cancer of colon and rectum. In: W J, J P, editors. Perez and Brady’s prinicile and practice of radiation oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013. p. 1221–30.

Minsky BD, Rödel C, Valentini V. Short-course radiation versus long-course chemoradiation for rectal cancer. JNCCN J Natl Compr Cancer Netw. 2012;10(10):1223–31.

Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg. 2006;93(10):1215–23.

Erlandsson J, Holm T, Pettersson D, Berglund Å, Cedermark B, Radu C, et al. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. Lancet Oncol. 2017;18(3):336–46.

Latkauskas T, Pauzas H, Kairevice L, Petrauskas A, Saladzinskas Z, Janciauskiene R, et al. Preoperative conventional chemoradiotherapy versus short-course radiotherapy with delayed surgery for rectal cancer: results of a randomized controlled trial. BMC Cancer [Internet]. 2016;16(1):927. Available from: http://bmccancer.biomedcentral.com/articles/10.1186/s12885-016-2959-9

Shi-Xin Liu, Zhi-Rui Zhou, Ling-Xiao Chen, Yong-Jing Yang, Zhi-De Hu, Tian-Song Zhang. Short-course Versus Long-course Preoperative Radiotherapy plus Delayed Surgery in the Treatment of Rectal Cancer: a Meta-analysis. Asian Pacific J Cancer Prev. 2015;16(14):5755–62.

Viani GA, Stefano EJ, Soares FV, Afonso SL. Evaluation of biologic effective dose and schedule of fractionation for preoperative radiotherapy for rectal cancer: Meta-analyses and meta-regression. Int J Radiat Oncol Biol Phys. 2011;80(4):985–91.

Zhou ZR, Liu SX, Zhang TS, Chen LX, Xia J, Hu Z De, et al. Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: A systematic review and meta-analysis. Surg Oncol. 2014;23(4):211–21.

Lee-Ying RM, Yin Y, Lim HJ, Cheung WY, Kennecke HF. Population-based assessment of disease-free survival (DFS) as a surrogate endpoint (SE) of 5-year overall survival (5Y OS) in stage I-III rectal (RC) and colon cancer (CC). J Clin Oncol [Internet]. 2016 May 20;34(15_suppl):3602. Available from: http://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.3602

Nelson VM, Benson AB 3rd. Pathological complete response after neoadjuvant therapy for rectal cancer and the role of adjuvant therapy. Curr Oncol Rep. 2013 Apr;15(2):152–61.

Chaudry M, Lei X, Gonzalez-Angulo AM, Mittendorf EA, Valero V, Tripathy D, et al. Recurrence and survival among breast cancer patients achieving a pathological complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat. 2015 Sep;153(2):417–23.

DOI: https://doi.org/10.32532/jori.v8i2.70 <